Mitochondrial dysfunction in the cochlea is thought to be an important cause of sensorineural hearing loss. Recently, we have established a novel rat model with acute hearing impairment caused by exposure to the mitochondrial toxin 3-nitropropionic acid (3-NP) to analyze the mechanism of cochlear mitochondrial dysfunction. Both permanent and temporary threshold shifts were observed in this model depending on the amount of 3-NP used to induce hearing impairment. In this study, we demonstrate cochlear morphological changes in the permanent threshold shift model. Marked degeneration was detected in type 2 fibrocytes in the spiral prominence, type 4 fibrocytes in the spiral ligament, marginal cells and intermediate cells in the stria vascularis 3 h after 3-NP administration; these changes were progressive for at least 14 days. Less prominent degeneration was detected in type 1 and type 3 fibrocytes in the spiral ligament. These results indicate that permanent threshold shift caused by acute cochlear mitochondrial dysfunction is primarily mediated by cellular degeneration in the lateral wall of the cochlea, and suggest that therapy of cochlear hearing loss due to acute energy failure may be achieved through protection and regeneration of the cochlear lateral wall.

1.
Alston TA, Mela I, Bright HJ: 3-Nitropropionate, the toxic substance of Indigofera, is a suicide inactivator of succinate dehydrogenase. Proc Natl Acad Sci USA 1977;74:3767–3771.
2.
Ashmore JF: A fast motile response in guinea-pig outer hair cells: The cellular basis of the cochlear amplifier. J Physiol 1987;388:323–347.
3.
Billett TE, Thorne PR, Gavin JB: The nature and progression of injury in the organ of Corti during ischemia. Hear Res 1989;41:189–198.
4.
Braverman I, Jaber L, Levi H, Adelman C, Arons KS, Fischel-Ghodsian N, Shohat M, Elidan J: Audiovestibular findings in patients with deafness caused by a mitochondrial susceptibility mutation and precipitated by an inherited nuclear mutation or aminoglycosides. Arch Otolaryngol Head Neck Surg 1996;122:1001–1004.
5.
Brouillet E, Hantraye P, Ferrante RJ, Dolan R, Leroy-Willig A, Kowall NW, Beal MF: Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates. Proc Natl Acad Sci USA 1995;92:7105–7109.
6.
Brown MC, Nuttall AL, Masta RI, Lawrence M: Cochlear inner hair cells: Effects of transient asphyxia on intracellular potentials. Hear Res 1983;9:131–144.
7.
Coles CJ, Edmondson DE, Singer TP: Inactivation of succinate dehydrogenase by 3-nitropropionate. J Biol Chem 1979;254:5161–5167.
8.
Flagella M, Clarke LL, Miller ML, Erway LC, Giannella RA, Andringa A, Gawenis LR, Kramer J, Duffy JJ, Doetschman T, Lorenz JN, Yamoah EN, Cardell EL, Shull GE: Mice lacking the basolateral Na-K-2Cl cotransporter have impaired epithelial chloride secretion and are profoundly deaf. J Biol Chem 1999;274:26946–26955.
9.
Gao J, Hoshino T, Iwasaki S, Wu R: Photochemically induced focal cochlear lesions in the guinea pig. 1. DAB staining and SEM study. Microsc Res Tech 1998;41:323–333.
10.
Green DR, Reed JC: Mitochondria and apoptosis. Science 1998;281:1309–1312.
11.
Hakuba N, Matsubara A, Hyodo J, Taniguchi M, Maetani T, Shimizu Y, Tsujiuchi Y, Shudou M, Gyo K: AMPA/kainate-type glutamate receptor antagonist reduces progressive inner hair cell loss after transient cochlear ischemia. Brain Res 2003;979:194–202.
12.
Hamilton BF, Gould DH: Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage. Acta Neuropathol (Berl) 1987;72:286–297.
13.
Hoya N, Okamoto Y, Kamiya K, Fujii M, Matsunaga T: A novel animal model of acute cochlear mitochondrial dysfunction. Neuroreport 2004;15:1597–1600.
14.
Huang T, Cheng AG, Stupak H, Liu W, Kim A, Staecker H, Lefebvre PP, Malgrange B, Kopke R, Moonen G, Van De Water TR: Oxidative stress-induced apoptosis of cochlear sensory cells: Otoprotective strategies. Int J Dev Neurosci 2000;18:259–270.
15.
Hutchin TP, Cortopassi GA: Mitochondrial defects and hearing loss. Cell Mol Life Sci 2000;57:1927–1937.
16.
Kikuchi T, Kimura RS, Paul DL, Adams JC : Gap junction in the rat cochlea: immunohistochemical and ultrastructural analysis. Anat Embryol 1995;191:101–118.
17.
Kimura R, Perlman HB: Arterial obstruction of the labyrinth. 1. Cochlear changes. Ann Otol Rhinol Laryngol 1958;67:5–23.
18.
Koga K, Hakuba N, Watanabe F, Shudou M, Nakagawa T, Gyo K: Transient Cochlear ischemia causes delayed cell death in the organ of Corti: An experimental study in gerbils. J Comp Neurol 2003;456:105–111.
19.
Kong W, Ren T, Nuttall AL: Electrophysiological and morphological evaluation of the acute ototoxicity of sodium nitroprusside. Hear Res 1996;99:22–30.
20.
Mattox DE, Simmons FB: Natural history of sudden sensorineural hearing loss. Ann Otol Rhinol Laryngol 1977;86:463–480.
21.
Minowa O, Ikeda K, Sugitani Y, Oshima T, Nakai S, Katori Y, Suzuki M, Furukawa M, Kawase T, Zheng Y, Ogura M, Asada Y, Watanabe K, Yamanaka H, Gotoh S, Nishi-Takeshima M, Sugimoto T, Kikuchi T, Takasaka T, Noda T: Altered cochlear fibrocytes in a mouse. Science 1999;285:1408–1411.
22.
Miyashita H, Iwasaki S, Hoshino T: Photochemically induced focal cochlear lesions in the guinea pig. 2. A transmission electron microscope study. Microsc Res Tech 1998;41:334–340.
23.
Nam Y, Stover T, Hartman SS, Altschuler RA: Upregulation of glial cell line-derived neurotrophic factor (GDNF) in the rat cochlea following noise. Hear Res 2000;146:1–6.
24.
Nicholls DG, Budd SL: Mitochondria and neuronal survival. Physiol Rev 2000;80:315–360.
25.
Nuttall AL, Lawrence M: Intracellular potential changes of Corti’s organ with anoxia. Arch Otolaryngol 1979;105:574–578.
26.
Ohlemiller KK, Dugan LL: Elevation of reactive oxygen species following ischemia – Reperfusion in mouse cochlea observed in vivo. Audiol Neurootol 1999;4:219–228.
27.
Pai N, Zdanski CJ, Gregory CW, Prazma J, Carrasco V: Sodium nitroprusside/nitric oxide causes apoptosis in spiral ganglion cells. Otolaryngol Head Neck Surg 1998;119:323–330.
28.
Perlman HB, Kimura R, Fernandez C: Experiments on temporary obstruction of the internal auditory artery. Laryngoscope 1959;69:591–613.
29.
Plontke SKR, Wood AW, Salt AN: Analysis of gentamicin kinetics in fluids of the inner ear with round window administration. Otol Neurotol 2002;23:967–974.
30.
Puel JL, Pujol R, Tribillac F, Ladrech S, Eybalin M: Excitatory amino acid antagonists protect cochlear auditory neurons from excitotoxicity. J Comp Neurol 1994;341:241–256.
31.
Pujol R, Puel JL, Eybalin M: Implication of non-NMDA and NMDA receptors in cochlear ischemia. Neuroreport 1992;3:299–302.
32.
Quick CA, Duvall AJ: Early changes in the cochlea duct from ethacrynic acid: An electron microscopic evaluation. Laryngoscope 1970;80:954–965.
33.
Rao DB, Fechter LD: Increased noise severity limits potentiation of noise induced hearing loss by carbon monoxide. Hear Res 2000;150:205–214.
34.
Ruan RS, Leong SK, Yeoh KH: Ototoxicity of sodium nitroprusside. Hear Res 1997;114:169–178.
35.
Saijo S, Kimura RS: Distribution of HRP in the inner ear after injection into the middle ear cavity. Acta Otolaryngol 1984;97:593–610.
36.
Salt AN: Dynamics of the inner ear fluids; in Jahn AF, Santos-Sacchi J (eds): Physiology of the Ear, ed 2. San Diego, Singular, Thompson Learning, 2001, pp 333–355.
37.
Salt AN, Ma Y: Quantification of solute entry into cochlear perilymph through the round window membrane. Hear Res 2001;154:88–97.
38.
Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea: Estimation by tracer perfusion. Hear Res 1991a;56:29–36.
39.
Salt AN, Ohyama K, Thalmann R: Radial communication between the perilymphatic scalae of the cochlea: Estimation by bolus injection into the sealed cochlea. Hear Res 1991b;56:37–43.
40.
Santos-Sacchi J: Asymmetry in voltage-dependent movements of isolated outer hair cells from the organ of Corti. J Neurosci 1989;9:2954–2962.
41.
Santos-Sacchi J: Cell coupling in Corti’s organ. Brain Res Brain Res Rev 2000;32:167–171.
42.
Santos-Sacchi J: Cochlear physiology; in Jahn AF, Santos-Sacchi J (eds): Physiology of the Ear, ed 2. San Diego, Singular, Thompson Learning, 2001, pp 357–391.
43.
Santos-Sacchi J, Dilger JP: Whole cell currents and mechanical responses of isolated outer hair cells. Hear Res 1988;35:143–150.
44.
Schmiedt RA, Okamura H, Lang H, Schulte BA: Ouabain application to the round window of the gerbil cochlea: A model of auditory neuropathy and apoptosis. J Assoc Res Otolaryngol 2002;3:223–233.
45.
Schuknecht HF: Further observations of presbycusis. Arch Otolaryngol 1964;80:369–382.
46.
Spicer SS, Schulte BA: The fine structure of spiral ligament cells relates to ion return to the stria and varies with place-frequency. Hear Res 1996;100:80–100.
47.
Stover T, Nam Y, Gong TL, Lomax MI, Altschuler RA: Glial cell line-derived neurotrophic factor (GDNF) and its receptor complex are expressed in the auditory nerve of the mature rat cochlea. Hear Res 2001;155:143–151.
48.
Sue CM, Lipsett LJ, Crimmins DS, Tsang CS, Boyages SC, Presgrave CM, Gibson WPR, Byrne E, Morris JGL: Cochlear origin of hearing loss in MELAS syndrome. Ann Neurol 1998;43:350–359.
49.
Tabuchi K, Tsuji S, Fujihira K, Oikawa K, Hara A, Kusakari J: Outer hair cells functionally and structurally deteriorate during reperfusion. Hear Res 2002;173:153–163.
50.
Tawackoli W, Chen G, Fechter LD: Disruption of cochlear potentials by chemical asphyxiants cyanide and carbon monoxide. Neurotoxicol Teratol 2001;23:157–165.
51.
Thalmann R, Thalmann I, Ise I, Paloheimo S: Noxious effects upon cochlear metabolism. Laryngoscope 1977;87:699–721.
52.
Tsuji S, Tabuchi K, Hara A, Kusakari J: Long-term observations on the reversibility of cochlear dysfunction after transient ischemia. Hear Res 2002;166:72–81.
53.
Wangemann P: Comparison of ion transport mechanisms between vestibular dark cells and strial marginal cell. Hear Res 1995;90:149–157.
54.
Wangemann P, Schacht J: Homeostatic mechanisms in the cochlea; in Dallos P, Popper AN, Fay RR (eds): The Cochlea. New York, Springer, 1996, pp 130–185.
55.
Wu R, Hoshino T: Changes in off-lesion endocochlear potential following localized lesion in the lateral wall. Acta Otolaryngol 1999;119:550–554.
56.
Wu R, Hoshino T: Long-term changes in off-lesion endocochlear potential after induction of localized lesions in the lateral wall. Ann Otol Rhinol Laryngol 2001;110:271–276.
57.
Yamane H, Nakai Y, Takayama M, Iguchi H, Nakagawa T, Kojima A: Appearance of free radicals in the guinea pig inner ear after noise-induced acoustic trauma. Eur Arch Otorhinolaryngol 1995;252:504–508.
58.
Yamasoba T, Oka Y, Tsukuda K, Nakamura M, Kaga K: Auditory findings in patients maternally inherited diabetes and deafness harboring a point mutation in the mitochondrial transfer RNA Leu (UUR) gene. Laryngoscope 1996;106:49–53.
59.
Ylikoski J, Pirvola U, Virkkala J, Suvanto P, Liang XQ, Magal E, Altschuler R, Miller JM, Saarma M: Guinea pig auditory neurons are protected by glial cell line-derived growth factor from degeneration after noise trauma. Hear Res 1998;124:17–26.
60.
Zidanic M, Brownell WE: Fine structure of the intracochlear potential field. 1. The silent current. Biophys J 1990;57:1253–1268.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.